GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 745 filers reported holding GLAXOSMITHKLINE PLC in Q3 2016. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $132,000 | +2100.0% | 3,023 | +2190.2% | 0.04% | +1750.0% |
| Q4 2021 | $6,000 | -98.6% | 132 | -98.7% | 0.00% | -99.2% |
| Q3 2016 | $435,000 | +0.7% | 10,065 | +1.0% | 0.25% | -9.0% |
| Q2 2016 | $432,000 | -2.9% | 9,965 | -9.1% | 0.28% | -8.3% |
| Q1 2016 | $445,000 | +10.7% | 10,965 | +10.0% | 0.30% | +11.0% |
| Q4 2015 | $402,000 | +0.2% | 9,965 | -4.3% | 0.27% | -1.1% |
| Q3 2015 | $401,000 | -7.6% | 10,417 | 0.0% | 0.28% | +5.3% |
| Q2 2015 | $434,000 | -24.3% | 10,417 | -16.1% | 0.26% | -23.8% |
| Q1 2015 | $573,000 | +6.3% | 12,417 | -1.6% | 0.34% | +9.6% |
| Q4 2014 | $539,000 | -7.1% | 12,617 | 0.0% | 0.31% | -9.8% |
| Q3 2014 | $580,000 | +1712.5% | 12,617 | +1995.8% | 0.35% | +1731.6% |
| Q2 2014 | $32,000 | 0.0% | 602 | 0.0% | 0.02% | -13.6% |
| Q1 2014 | $32,000 | 0.0% | 602 | 0.0% | 0.02% | -12.0% |
| Q4 2013 | $32,000 | – | 602 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
| Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
| KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
| Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
| EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
| Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
| Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
| Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
| Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
| CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |